13F Data
13F filer · CIK 1907884

Kynam Capital Management, LP

PRINCETON, NJ · filing since Q4 2021 · last filing Aug 14, 2026
Reported value
$1.8B
+$188.3M vs prior
Positions
32
New / sold out
5 / 12
Added / reduced
12 / 6
Turnover
15.7%
buys $269.5M · sells $302.9M
Top-10 weight
72.7%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedVIRIDIAN THERAPEUTICS INC+4,112,225+175.6%+$75.5M
AddedLEGEND BIOTECH CORP+1,424,910+90.4%+$41.2M
AddedRELAY THERAPEUTICS INC+1,875,741+131.7%+$35.1M
AddedCYTOMX THERAPEUTICS INC.+6,690,000+44.6%+$25.1M
AddedTRAVERE THERAPEUTICS INC+430,982+27.5%+$24.5M
NewSUMMIT THERAPEUTICS INC+1,200,000–+$17.5M
AddedIMMUNOCORE HLDGS PLC+490,063+55.4%+$15.6M
NewINSMED INC+100,000–+$10.7M
AddedUROGEN PHARMA LTD+186,814+8.3%+$6.9M
NewPARABILIS MEDICINES INC+250,000–+$6.8M
7 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outKALVISTA PHARMACEUTICALS INC-1,820,954-100.0%$-36.7M
Sold outAPELLIS PHARMACEUTICALS INC-825,000-100.0%$-33.2M
ReducedBIOCRYST PHARMACEUTICALS INC-3,158,135-55.6%$-31.6M
ReducedBEAM THERAPEUTICS INC-841,393-22.9%$-28.9M
Sold outTRAVERE THERAPEUTICS INCCALL-800,000-100.0%$-23.8M
ReducedVERA THERAPEUTICS INC-508,165-15.0%$-21.8M
Sold outREVOLUTION MEDICINES INCPUT-207,500-100.0%$-20.2M
ReducedCELLDEX THERAPEUTICS INC NEW-517,659-8.9%$-19.3M
Sold outSOLENO THERAPEUTICS INC-560,000-100.0%$-18.7M
Sold outEVOMMUNE INC-625,496-100.0%$-14.4M
8 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $187.1MQ1 2022: $308.3MQ2 2022: $391.6MQ3 2022: $474.6MQ4 2022: $651.9MQ1 2023: $774.6MQ2 2023: $727.1MQ3 2023: $611.4MQ4 2023: $902.6MQ1 2024: $955.5MQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.7BQ1 2025: $1.2BQ2 2025: $928.8MQ3 2025: $1.3BQ4 2025: $1.6BQ1 2026: $1.6BQ2 2026: $1.8B
Q4 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1CELLDEX THERAPEUTICS INC NEWCOM NEW5,322,908$198.1M10.95%
2SYNDAX PHARMACEUTICALS INCCOM8,050,959$176.0M9.73%
3VAXCYTE INCCOM2,922,335$169.9M9.39%
4COGENT BIOSCIENCES INCCOM3,667,097$141.9M7.84%
5VERA THERAPEUTICS INCCL A2,890,059$124.0M6.85%
6VIRIDIAN THERAPEUTICS INCCOM6,453,877$118.6M6.55%
7TRAVERE THERAPEUTICS INCCOM2,000,000$113.6M6.28%
8BEAM THERAPEUTICS INCCOM2,840,792$97.5M5.39%
9UROGEN PHARMA LTDCOM2,434,207$89.6M4.95%
10LEGEND BIOTECH CORPSPONSORED ADS3,001,205$86.7M4.79%
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.